why choose us

First received: April 21, 2023

Clinical Trial: A Study of Doxycycline to Treat Chlamydial Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chlamydial Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection

Brief Summary: This is a Phase 4 blinded, randomized, active-controlled, non-inferiority trial.Persons of any gender identity will be eligible.Final evaluable population will include a minimum 596 individuals: 298 persons assigned female sex at birth (AFAB) with confirmed urogenital chlamydia (CT) and 298 persons assigned male at birth (AMAB) with confirmed rectal chlamydia (CT).Approximately 664 participants will be enrolled to achieve a minimum 596 participants who contribute primary outcome data.Randomization will be…

Read more